Skip to Main Content

Attention brand-name drug makers: the Food and Drug Administration may soon publicly shame you for thwarting generic rivals.

The idea is to break a logjam caused by an FDA program that is designed to boost safety.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!


Comments are closed.